로딩 중…
StockDiggingStockDigging

Xeris Biopharma Holdings, Inc.

XERS· NASDAQ
$6.95+0.72%
2026-06-18

Price Chart

Xeris Biopharma Holdings, Inc.+51.75%

Financials

※ FY = Fiscal Year

Investment Metrics(as of 2026-06-18)

MetricValue
Size
Market Cap$1.20B
Revenue$315M
Net Income$12M
Total Assets$392M
Net Assets$13M
Value
P/E99.92x
P/B92.22x
P/S3.81x
EV/EBITDA25.05x
FCF Yield3.94%
Profitability
ROE92.29%
ROA3.06%
Op. Margin11.40%
Revenue Growth38.27%
Financial Health
Debt Ratio2912.94%
Total Debt$37M
FCF$47M
Cash$112M
Current Ratio2.12x
Net Debt/EBITDA-1.66x
Performance
1Y Return51.75%
1M Return17.40%
From 52W High-31.05%
1Y MDD-46.57%
Trading
Volume1,804,127 shares
Trading Value$13M
Per Share
BPS$0.08